Bronstein, Gewirtz and Grossman, LLC Announces Investigation into HilleVax, Inc. and Encourages Shareholders to Contact the Company!

NEW YORK, NY / ACCESSWIRE / July 15, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of HilleVax, Inc. (“HilleVax” or “the Company”) (NASDAQ: HLVX). Investors who purchased HilleVax securities are encouraged to obtain additional information and assist in the investigation by visiting the Company’s website: bgandg.com/HLVX.

Survey details

On July 8, 2024, Fierce Biotech published an article stating, “HilleVax shares fell after the vaccine biotech’s sole clinical-stage candidate failed a Phase 2b trial in norovirus-related acute gastroenteritis (AGE).” The article continued, “The virus-like particle vaccine, called HIL-214, missed all primary and secondary endpoints in the NEST-IN1 study of more than 2,800 infants approximately five months old in the United States and Latin America.” Shareholders suffered damages on this news.

And after?

If you have knowledge of facts relevant to this investigation or have purchased HilleVax securities, you can assist in this investigation by visiting the company’s website: bgandg.com/HLVX. You may also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 332-239-2660.

It costs you nothing

We represent investors in class actions on a contingency fee basis. This means that we will ask the court to reimburse us for costs and attorneys’ fees, typically a percentage of the total amount recovered, only if we are successful in our case.

Why Bronstein, Gewirtz & Grossman

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm representing investors in securities fraud class actions and shareholder derivative lawsuits. Our firm has recovered hundreds of millions of dollars for investors nationwide.

Lawyer Advertising. Past results do not guarantee similar results.

Contact

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Nathan Miller
332-239-2660 | (protected email)

SOURCE: Bronstein, Gewirtz & Grossman, LLC